Bio-Rad Laboratories Financial Health
How is Bio-Rad Laboratories's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: BIO's short term assets ($3.2B) exceed its short term liabilities ($613.7M).
Long Term Liabilities: BIO's short term assets ($3.2B) exceed its long term liabilities ($3.1B).
Debt to Equity History and Analysis
Debt Level: BIO has more cash than its total debt.
Reducing Debt: BIO's debt to equity ratio has reduced from 15% to 13.3% over the past 5 years.
Debt Coverage: BIO's debt is well covered by operating cash flow (40.9%).
Interest Coverage: BIO earns more interest than it pays, so coverage of interest payments is not a concern.